{"id":17092,"date":"2014-03-10T12:02:55","date_gmt":"2014-03-10T16:02:55","guid":{"rendered":"http:\/\/sciencebusiness.technewslit.com\/?p=17092"},"modified":"2014-03-10T12:02:55","modified_gmt":"2014-03-10T16:02:55","slug":"smartphone-obstetrics-app-gains-2m-angel-public-funding","status":"publish","type":"post","link":"https:\/\/technewslit.com\/sciencebusiness\/?p=17092","title":{"rendered":"Smartphone Obstetrics App Gains $2M Angel, Public Funding"},"content":{"rendered":"
\"Phone<\/a>
Phone Oximeter (LionsGate Technologies)<\/figcaption><\/figure>\n

10 March 2014.\u00a0LionsGate Technologies, a medical device developer in Vancouver, British Columbia, received $2 million in private and public financing for its smartphone app measuring blood oxygen levels in pregnant women. The funds\u00a0will support clinical trials and scaling up for production of LionsGate’s\u00a0Phone Oximeter<\/a>, a device that checks for risks of developing high blood pressure that can lead to\u00a0preeclampsia, causing serious complications and high numbers of infant and maternal death.<\/p>\n

The new round of financing for the\u00a0Phone Oximeter is divided between Vancouver angel investor\u00a0Irfhan Rajani<\/a> and Grand Challenges Canada<\/a>, an initiative supported by the Canadian government that funds medical innovations aimed at improving health conditions in low-resource countries. Both\u00a0Rajani and\u00a0Grand Challenges Canada are providing $1 million.<\/p>\n

Preeclampsia<\/a> is a rapidly progressive and dangerous condition usually diagnosed with a pregnant woman’s blood pressure readings that develops during the second or third trimester, and often requires immediate delivery of the baby. Statistics collected by the\u00a0Preeclampsia Foundation<\/a> indicate the disorder is the cause of 13 percent of all maternal deaths worldwide, estimated at 1,400 per day or 500,000 per year.<\/span><\/p>\n

The Phone Oximeter measures\u00a0proportions of oxygen-carrying molecules in the blood, a factor known as\u00a0pulse oximetry that’s\u00a0monitored routinely among hospital patients to detect\u00a0hypoxemia,\u00a0a condition where blood in the arteries is not sufficiently oxygenated.\u00a0LionsGate says the device makes it possible to find those at risk of developing preeclampsia\u00a0much earlier through their blood oxygen levels,\u00a0using a predictive score that can identify some 80 percent of cases of pregnant women at risk of high blood pressure.<\/span><\/p>\n

The\u00a0Phone Oximeter uses the same principle of measuring blood oxygen levels as found in hospital equipment, shining red and infrared light on the skin and measuring the waves that pass through, from sensors worn on the fingertip. The proportions of different light waves passing through are then calculated into a percentage of oxygen saturation. However, the\u00a0Phone Oximeter takes advantage of computing power in mobile phones to analyze the readings and return blood oxygen measurements, as well as communicate results from the point of care in remote locations,\u00a0without the need for highly trained medical staff.<\/p>\n

LionsGate\u00a0says the\u00a0Phone Oximeter can test for\u00a0preeclampsia risks well before hypertension develops in the pregnant woman, when it is possible to take corrective actions.\u00a0With the mobile phone platform, the device’s cost will also be much lower than hospital equipment; its target price is $40.00.<\/p>\n

LionsGate is a spin-off company<\/a>\u00a0from University of British Columbia, Child & Family Research Institute, and BC Children\u2019s Hospital, all in Vancouver. Electrical and Computer Engineering in Medicine<\/a>, a\u00a0University of British Columbia\u00a0research institute, conducted the studies leading to the\u00a0Phone Oximeter.\u00a0Mark Ansermino and Guy Dumont are co-directors<\/a> of the research center, as well as two of the lead researchers for LionsGate on the project, with\u00a0Peter von Dadelszen<\/a>, professor of maternal fetal medicine at the university.<\/p>\n

Read more:<\/p>\n